Veeva Systems Inc. (VEEV): Price and Financial Metrics

Veeva Systems Inc. (VEEV)

Today's Latest Price: $281.92 USD

7.96 (2.91%)

Updated Sep 28 6:40pm

Add VEEV to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 70 in Medical - Services

See all "A" rated Strong Buy stocks

VEEV Stock Summary

  • With a market capitalization of $42,520,982,071, Veeva Systems Inc has a greater market value than 95.47% of US stocks.
  • VEEV's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 863.23 -- higher than 96.22% of US-listed equities with positive expected earnings growth.
  • The price/operating cash flow metric for Veeva Systems Inc is higher than 96.35% of stocks in our set with a positive cash flow.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Veeva Systems Inc are SEDG, NVCR, MPWR, HUYA, and QLYS.
  • VEEV's SEC filings can be seen here. And to visit Veeva Systems Inc's official web site, go to
VEEV Daily Price Range
VEEV 52-Week Price Range

VEEV Stock Price Chart Technical Analysis Charts

VEEV Price/Volume Stats

Current price $281.92 52-week high $298.76
Prev. close $273.96 52-week low $118.11
Day low $277.42 Volume 1,248,600
Day high $287.18 Avg. volume 1,269,691
50-day MA $266.74 Dividend yield N/A
200-day MA $198.71 Market Cap 42.52B

Veeva Systems Inc. (VEEV) Company Bio

Veeva Systems provides cloud-based software solutions for the life sciences industry in North America, Europe, the Asia Pacific, and Latin America. The company was founded in 2007 and is based in Pleasanton, California.

VEEV Latest News Stream

Event/Time News Detail
Loading, please wait...

VEEV Latest Social Stream

Loading social stream, please wait...

View Full VEEV Social Stream

Latest VEEV News From Around the Web

Below are the latest news stories about Veeva Systems Inc that investors may wish to consider to help them evaluate VEEV as an investment opportunity.

Why Is Veeva (VEEV) Up 1.4% Since Last Earnings Report?

Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | September 26, 2020

5 Investing Criteria I've Used to Beat the Market

With thousands of stocks to pick from and a multitude of financial metrics one can use to judge companies' performance and growth potential, how can investors be sure they are making the best possible decisions? For me, "solid" revenue growth means at least 15% year over year, and "sustained" means it has continued for years, not just a few quarters. Since 2016, it has put up annual revenue growth in excess of 45%.

Yahoo | September 25, 2020

Veeva CRM to Help Medis Deliver Customized Experience to HCPs

Veeva Systems' (VEEV) CRM will be lending Medis teams a flexible solution that adapts to the unique go-to market strategies of every customer.

Yahoo | September 24, 2020

Veeva Systems Again Enlisted To Help A Covid-19 Treatment Study, Making It Stock Of The Day

Veeva Systems software has been enlisted to help yet another biotech customer work to develop a possible Covid-19 treatment, far from the first such customer for the Stock of the Day.

Yahoo | September 23, 2020

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

Readers who have followed along know that Veeva Systems was one of our original "virus" plays back when the whole pandemic was just reaching U.S. shores, and thus impacting U.S. financial markets, not to mention deeply impacting human lives and families. To refresh, Veeva is not a pharmaceutical, or a biotech. Veeva is a cloud-based software provider that focuses on the life sciences industry.

Yahoo | September 23, 2020

Read More 'VEEV' Stories Here

VEEV Price Returns

1-mo 2.86%
3-mo 16.39%
6-mo 80.53%
1-year 84.64%
3-year 399.77%
5-year 1,104.79%
YTD 100.43%
2019 57.48%
2018 61.58%
2017 35.82%
2016 41.07%
2015 9.24%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7709 seconds.